Characterization of Acute Lymphoblastic Leukemia Subtypes in Moroccan Children

Table 4

Clinical and biological features according to CD10 expression in children with ALL.

		No. of patients (%)
		pB-cell ALL (𝑛=216)			T-cell ALL (𝑛=47)
Features	Total of patients	CD10−	CD10+	𝑃 value	CD10−	CD10+	𝑃 value
Gender				.92			.24
F	113	9 (9.09)	90 (90.91)		9 (64.29)	5 (35.71)
M	150	10 (8.55)	107 (91.45)		28 (84.85)	5 (15.15)
Leukocyte count (×10^9/L)				.31			.81
<50	177	12 (4.71)	150 (92.59)		11 (73.33)	4 (26.67)
>50	85	7 (13.21)	46 (86.79)		26 (81.25)	6 (18.75)
FAB subtype				.67			.89
L1	135	10 (9.09)	100 (90.91)		19 (76.00)	6 (24.00)
L2	98	5 (6.33)	74 (93.67)		15 (78.95)	4 (21.05)
Age (Y)				.27			.038^‡
<1	6	0 (0.00)	5 (100)		0 (0.00)	1 (100)
1–10	147	11 (7.24)	141 (92.76)		20 (90.91)	2 (9.09)
>10	83	8 (13.56)	51 (86.44)		17 (70.83)	7 (29.17)

ALL: acute lymphoblastic leukaemia, F: female, M: male, Y: year. ^‡𝑃≤.05 (statistically significant).